Ethanol interference with morphine metabolism in isolated guinea pig hepatocytes.

It has previously been shown that guinea pig hepatocytes metabolise morphine in a fashion similar to humans. The metabolism of morphine (5 muM) and the formation of metabolites morphine-3-glucuronide, morphine-6-glucuronide and normorphine was studied in the absence and presence of ethanol (5, 10, 25, 60 and 100 mM) in freshly isolated guinea pig hepatocytes. In order to gain more detailed information, a mathematical model was estimated on experimental data and used to analyse the effects of ethanol on the reaction rates of the different morphine metabolites. Ethanol inhibited the rate of morphine elimination in a dose-related manner, at the high ethanol concentrations the elimination rate was 40 per cent of the control rate. The formation of morphine-glucuronides was influenced in a biphasic manner. Five and 10 mM ethanol increased both the morphine-3-glucuronide and morphine-6-glucuronide levels after 60 min incubation compared to the control, whereas at the higher ethanol concentrations (25-100 mM) the levels of morphine-glucuronides were reduced. Data from the mathematical model, however, demonstrated that the reaction rates for morphine-glucuronide formation were decreased at all ethanol concentrations and in a dose-dependent manner, the interpretation of this being that at the lower (5 and 10 mM) ethanol concentrations employed in this study, other metabolic pathways of morphine are more heavily inhibited than the glucuronidations, resulting in a shunting towards morphine-3-glucuronide and morphine-6-glucuronide. The pharmacodynamic consequences of these pharmacokinetic effects are thus somewhat difficult to predict since morphine-6-glucuronide has a higher agonist potency than morphine. At high concentrations ethanol inhibition of morphine metabolism will increase the concentration of morphine and subsequently the euphoric and the toxic effects. The lower quantities of morphine-6-glucuronide formed in the presence of high ethanol concentrations on the other hand most probably imply reduction of such effects and the net pharmacodynamic effect would be uncertain. At low ethanol concentrations, however, morphine-6-glucuronide concentrations increased and morphine metabolism was less inhibited leading to a possible potentiation of the effects of morphine. Thus, a low ethanol concentration might exert a more pronounced ethanol-drug effect interaction than a higher ethanol concentration.

[1]  J. Mørland,et al.  Distribution of morphine 6-glucuronide and morphine across the blood-brain barrier in awake, freely moving rats investigated by in vivo microdialysis sampling. , 1995, The Journal of pharmacology and experimental therapeutics.

[2]  D Westerling,et al.  Plasma Concentrations of Morphine, Morphine‐3‐Glucuronide, and Morphine‐6‐Glucuronide After Intravenous and Oral Administration to Healthy Volunteers: Relationship to Nonanalgesic Actions , 1995, Therapeutic drug monitoring.

[3]  P. Dodd,et al.  Pharmacology of morphine and morphine-3-glucuronide at opioid, excitatory amino acid, GABA and glycine binding sites. , 1994, Pharmacology & toxicology.

[4]  M. Plotkine,et al.  Morphine and morphine metabolite kinetics in the rat brain as assessed by transcortical microdialysis. , 1994, Life sciences.

[5]  J. Mørland,et al.  Morphine-6-glucuronide: a potent stimulator of locomotor activity in mice. , 1994, Life sciences.

[6]  S. Bartlett,et al.  The excitatory effects of morphine-3-glucuronide are attenuated by LY274614, a competitive NMDA receptor antagonist, and by midazolam, an agonist at the benzodiazepine site on the GABAA receptor complex. , 1994, Life sciences.

[7]  E. Kalso,et al.  Intrathecal morphine-3-glucuronide does not antagonize spinal antinociception by morphine or morphine-6-glucuronide in rats. , 1993, European journal of pharmacology.

[8]  J. Mørland,et al.  Different biotransformation of morphine in isolated liver cells from guinea pig and rat. , 1993, Biochemical pharmacology.

[9]  A. Somogyi,et al.  Plasma Concentrations and Renal Clearance of Morphine, Morphine-3-Glucuronide and Morphine-6-Glucuronide in Cancer Patients Receiving Morphine , 1993, Clinical pharmacokinetics.

[10]  A. Dickenson,et al.  Lack of effect of morphine-3-glucuronide on the spinal antinociceptive actions of morphine in the rat: an electrophysiological study , 1993, Pain.

[11]  M. Hammarlund-Udenaes,et al.  Pharmacokinetics and pharmacodynamics of morphine‐3‐glucuronide in rats and its influence on the antinociceptive effect of morphine , 1993, Biopharmaceutics & drug disposition.

[12]  S. Joel,et al.  The analgesic activity of morphine-6-glucuronide. , 1992, British journal of clinical pharmacology.

[13]  B. Monsarrat,et al.  Further evidence that morphine-6 beta-glucuronide is a more potent opioid agonist than morphine. , 1992, The Journal of pharmacology and experimental therapeutics.

[14]  J. Morley,et al.  Differential inhibition of hepatic morphine UDP-glucuronosyltransferases by metal ions. , 1992, Biochemical pharmacology.

[15]  M. Slevin,et al.  Morphine 6‐glucuronide: a metabolite of morphine with greater emetic potency than morphine in the ferret , 1992, British journal of pharmacology.

[16]  H. Thaler,et al.  The metabolite morphine‐6‐glucuronide contributes to the analgesia produced by morphine infusion in patients with pain and normal renal function , 1992, Clinical pharmacology and therapeutics.

[17]  T. Hedner,et al.  Morphine-3-glucuronide may functionally antagonize morphine-6-glucuronide induced antinociception and ventilatory depression in the rat , 1992, Pain.

[18]  L. Reiff,et al.  Morphine-6-glucuronide: receptor binding profile in bovine caudate nucleus. , 1991, Pharmacology & toxicology.

[19]  T. Hedner,et al.  Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. , 1991, European journal of pharmacology.

[20]  K. Franklin,et al.  Morphine-6-glucuronide contributes to rewarding effects of opiates. , 1991, Life sciences.

[21]  A. Somogyi,et al.  Mu receptor binding of some commonly used opioids and their metabolites. , 1991, Life sciences.

[22]  Y. Kumagai,et al.  A new metabolic pathway of morphine: in vivo and in vitro formation of morphinone and morphine-glutathione adduct in guinea pig. , 1990, The Journal of pharmacology and experimental therapeutics.

[23]  S. Peat,et al.  Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphine. , 1990, British journal of anaesthesia.

[24]  Maree T. Smith,et al.  Morphine-3-glucuronide--a potent antagonist of morphine analgesia. , 1990 .

[25]  G. Pasternak,et al.  Pharmacological characterization of morphine-6 beta-glucuronide, a very potent morphine metabolite. , 1989, The Journal of pharmacology and experimental therapeutics.

[26]  R. Palmour,et al.  Morphine-6-glucuronide: analgesic effects and receptor binding profile in rats. , 1988, Life sciences.

[27]  G. Pasternak,et al.  Morphine-6-glucuronide, a potent mu agonist. , 1987, Life sciences.

[28]  J. Mørland,et al.  Mechanisms behind the inhibitory effect of ethanol on the conjugation of morphine in rat hepatocytes. , 1986, The Journal of pharmacology and experimental therapeutics.

[29]  Y. Ohno,et al.  Morphine metabolism in isolated rat hepatocytes and its implications for hepatotoxicity. , 1986, Biochemical pharmacology.

[30]  J. Mørland,et al.  Ethanol inhibition of codeine and morphine metabolism in isolated rat hepatocytes. , 1986, The Journal of pharmacology and experimental therapeutics.

[31]  J. Svensson Determination of morphine, morphine-6-glucuronide and normorphine in plasma and urine with high-performance liquid chromatography and electrochemical detection , 1986 .

[32]  L. Kager,et al.  Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. , 1985, British journal of clinical pharmacology.

[33]  J. Brick,et al.  Tolerance and cross-tolerance to morphine and ethanol in mice selectively bred for differential sensitivity to ethanol. , 1983, Journal of studies on alcohol.

[34]  A. Rane,et al.  Determination of morphine, morphine-3-glucuronide and (tentatively) morphine-6-glucuronide in plasma and urine using ion-pair high-performance liquid chromatography. , 1982, Journal of chromatography.

[35]  F. J. Romero,et al.  Effect of ethanol on glutathione concentration in isolated hepatocytes. , 1980, The Biochemical journal.

[36]  B. Kissin Interactions of Ethyl Alcohol and Other Drugs , 1974 .

[37]  D. Friend,et al.  HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS , 1969, Journal of Cell Biology.